12:00 AM
 | 
Jan 16, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Memantine neurology data

Researchers from Kings College London and colleagues reported that memantine was ineffective in treating cognitive impairment and dementia in patients with Down syndrome in the double-blind, U.K. and Norwegian MEADOWS trial in 173 patients aged>=40 years old. Relative to placebo, memantine led to non-significantly greater mean changes from baseline to week...

Read the full 233 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >